Blend10 mg
BPC-157 + TB-500 Recovery Blend (10 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE10 mg (BPC-157 5 mg + TB-500 5 mg)
RECONSTITUTION3.0 mL bacteriostatic water
CONCENTRATION3.33 mg/mL total
ROUTESubcutaneous injection
FREQUENCYOnce daily
CYCLE LENGTH8–16 weeks
DOSE RANGE300–900 mcg combined daily
STORAGE−20 °C lyophilized / 2–8 °C reconstituted
Overview
Pre-blended BPC-157 + TB-500 for synergistic local + systemic tissue repair. At 3.33 mg/mL total, each 0.09 mL delivers ~150 mcg of each peptide.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 300 mcg (150 mcg each) | 9 units | 0.09 mL |
| Weeks 3–4 | 600 mcg (300 mcg each) | 18 units | 0.18 mL |
| Weeks 5+ | 900 mcg (450 mcg each) | 27 units | 0.27 mL |
Reconstitution Instructions
1.
Draw 3.0 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl/roll until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Recovery Blend Vials (10 mg): 2–3 vials
- ✓Insulin Syringes (U-100): 56 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 112 swabs
Dosing Protocol
Schedule
Once daily subcutaneously.
Cycle Structure
8–16 weeks.
Timing
Any consistent time. Inject near area of interest for BPC-157 localisation benefit.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Discard if solution becomes cloudy or contains visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.